MarketLens
Sign Up

Celcuity's REVTORPYK Approval: A Multi-Billion Dollar Breakthrough Despite High Expectations

1 months ago
SHARE THIS ON:

Celcuity's REVTORPYK Approval: A Multi-Billion Dollar Breakthrough Despite High Expectations

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News4 days ago

Celcuity: REVTORPYK Is Now A Commercial Story

Celcuity's REVTORPYK/gedatolisib gained FDA approval and NCCN Category 1 inclusion, de-risking adoption. SG&A surged for launch, but a $754M cash position funds operations into 2029, supporting a pote...
Stock News1 months ago

Gilead's Breast Cancer Drug Trodelvy Wins FDA Nod for Expanded Use

Gilead's Trodelvy won FDA approval for expanded use in first-line metastatic triple-negative breast cancer, broadening its addressable patient population.
Stock News2 months ago

Celcuity plunges after experimental breast cancer treatment data disappoints

Celcuity shares fell 25% on Tuesday, marking their largest one-day decline, after clinical data for its experimental breast cancer treatment showed efficacy that underperformed results from a previous...
Stock News2 months ago

Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits Near All-Time Highs

Revolution Medicines' pancreatic cancer pill reduced the risk of death by 60% and doubled survival rates in recent clinical trials. These results represent a significant breakthrough for the difficult...

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

Here's Why Nvidia (NVDA) Fell More Than Broader Market

Stock News1 hour ago

Pence: NVDA "Pivotal Chokepoint" of AI & Likes MSFT, AMZN, GOOGL in Mag 7

Stock News2 hours ago

QYLD Holders Left $56,700 Per $10,000 on the Table Chasing Twelve Years of Monthly Income

Stock News2 hours ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphabet Inc. - GOOG

Stock News2 hours ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alibaba Group Holding Limited of Class Action Lawsuit and Upcoming Deadlines – BABA